Lumida
/NRC
⌘K
National Research Corp

National Research Corp

NRC
$21.12USD↓-0.66%-0.14 today

MARKET CAP

467.2M

P/E (TTM)

23.4x

FWD P/E

22.2x

DAY RANGE

$21 – $22

52W RANGE

$11
$24

AI Summary

Stalk
TrimMedium

In Stage 4 decline, sustained lower highs and lower lows with price under sloping EMAs and moving averages confirms a downtrend. The active Lower Highs & Lower Lows pattern signals supply dominance and bearish control. Absence of mean reversion eligibility further supports a bearish medium-term bias. Tactically, selling into rallies toward the 9/20/50 EMA region is preferred, deferring execution until price approaches structural resistance.

  • ↑Earnings Yield of 0.43 offers income cushion during market swings.
  • ↑Positive TRCV growth underscores loyal customers and recurring revenue.
  • ↓27% stock drop post-earnings reveals market disappointment despite EPS growth.
Full analysis →

Buying

3

institutions

Selling

3

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY1.06 M22.89 M+85.50 K+38.2%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL325.38 K7.02 M+-15.40 K+21.3%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL122.21 K2.64 M+-49.64 K-9.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW64.09 K1.38 M+64.09 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL6.02 K130.23 K+-190.00+22.4%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUYNEW119.002.57 K+119.00+0.0%0.00%